---
$id: https://graph.org.ai/products/commodity/51101669
$type: Product
source: UNSPSC
code: "51101669"
title: "Monensin"
class: "51101600"
classTitle: "Amebicides and trichomonacides"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Monensin

**UNSPSC Code**: 51101669
**Class**: [Amebicides and trichomonacides](Amebicides and trichomonacides.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiprotozoal agent with the molecular formula C36H62O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 906O0YJ6ZP, chemically known as monensin, monosodium salt but generally known as monensin, which bears US NIH Compound Identifier 4243. European Medicines Agency schedules Monensin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09048MIG. The term MONENSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). Most nations schedule monensin under HS 29419000 and SITC 54139. As of Q4 2014, MONENSIN remains the US FDA Preferred Term for this commodity. Monensin bears US NLM identifiers UMLS ID C0026408 and NCI Concept Code C83971. SMILES: O1C(C2OC(CC2C)C2OC(O)(C(CC2C)C)CO)(CCC1C1(OC2(OC(C(C(O)C2)C)C(C(OC)C(C)C(=O)O)C)CC1)C)CC.

